The Pennant Group (PNTG) Stock Price, News & Analysis

Company Overview

The Pennant Group, Inc. is a healthcare services company that operates home health, hospice and personal care businesses, as well as senior living communities. Its services are designed to support older adults and other patients in their homes, residential settings and communities, with offerings that may include skilled nursing, therapy, hospice care, assisted living and memory care.

The company serves patients and residents through a network of affiliated operating companies and communities across multiple U.S. states. Its home-based services focus on clinical and supportive care delivered in patients’ residences, while its senior living operations provide housing, daily assistance and care services for older adults with varying needs.

The Pennant Group was formed as an independent public company through a 2019 spin-off from The Ensign Group. It uses a decentralized operating model that gives local leaders responsibility for managing services and developing their businesses. The company is led by Chief Executive Officer Brent Guerisoli.

Key Stats

• Today's Range: $38.82 to $39.81
• 50-Day Range: $36.76 to $42.48
• 52-Week Range: $22.25 to $42.74
• Volume: 184,039 shs
• Average Volume: 290,893 shs
• Market Capitalization: $1.39 billion
• P/E Ratio: 44.08
• Dividend Yield: N/A
• Price Target: $41.60
• Consensus Rating: Moderate Buy

The Pennant Group Stock Analysis - MarketRank™

The Pennant Group scored higher than 67% of companies evaluated by MarketBeat, and ranked 229th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.6 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

The Pennant Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on no strong buy ratings, 7 buy ratings, 1 hold rating, and no sell ratings.

Upside/Downside

The consensus price target for The Pennant Group is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

The Pennant Group has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 16.95%

Earnings Growth

Earnings for The Pennant Group are expected to grow by 16.95% in the coming year, from $1.18 to $1.38 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of The Pennant Group is 44.02, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.04.

Price to Earnings Ratio vs. Sector

The P/E ratio of The Pennant Group is 44.02, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.69.

Price to Earnings Growth Ratio

The Pennant Group has a PEG Ratio of 2.54. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

The Pennant Group has a P/B Ratio of 3.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.70% of the float of The Pennant Group has been sold short.

Short Interest Ratio / Days to Cover

The Pennant Group has a short interest ratio ("days to cover") of 3.77, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in The Pennant Group has recently increased by 13.85%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

The Pennant Group does not currently pay a dividend.

Dividend Growth

The Pennant Group does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.79

News Sentiment

The Pennant Group has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for The Pennant Group this week, compared to 3 articles on an average week.

Search Interest

2 people have searched for PNTG on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added The Pennant Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, The Pennant Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

6.90% of the stock of The Pennant Group is held by insiders.

Percentage Held by Institutions

85.88% of the stock of The Pennant Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 9/23/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:PNTG
• CIK: 1766400
• Web: www.pennantgroup.com
• Phone: 208-506-6100
• Fax: N/A
• Employees: 9,700
• Year Founded: 2010

Price Target and Rating

• Average Price Target for The Pennant Group: $41.60
• High Price Target: $48.00
• Low Price Target: $30.00
• Potential Upside/Downside: +4.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.88
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.90
• Trailing P/E Ratio: 44.08
• Forward P/E Ratio: 33.62
• P/E Growth: 2.54
• Net Income: $29.58 million
• Net Margins: 2.93%
• Pretax Margin: 4.77%
• Return on Equity: 10.33%
• Return on Assets: 4.20%

Debt

• Debt-to-Equity Ratio: 0.48
• Current Ratio: 1.20
• Quick Ratio: 1.20

Sales & Book Value

• Annual Sales: $947.71 million
• Price / Sales: 1.46
• Cash Flow: $1.30 per share
• Price / Cash Flow: 30.40
• Book Value: $10.82 per share
• Price / Book: 3.67

Miscellaneous

• Outstanding Shares: 34,930,000
• Free Float: 32,519,000
• Market Cap: $1.39 billion
• Optionable: Optionable
• Beta: 1.27